IIEF
International Index of Erectile Function
Start the test
Age range
18+ years old
Question count
15
Price
Free
Overview
The International Index of Erectile Function (IIEF) is a validated, multidimensional self-report instrument designed to assess the key dimensions of erectile function and sexual health in men. Developed by Rosen et al. (1997), the IIEF is widely recognized for its robustness and comprehensive approach to evaluating erectile dysfunction (ED). It is extensively utilized in both clinical practice and research settings to measure treatment outcomes and the severity of ED.
Purpose
- Assessment of Erectile Function: Providing a detailed evaluation of erectile function and related sexual health parameters.
- Clinical Diagnosis: Assisting clinicians in diagnosing erectile dysfunction and other sexual disorders.
- Treatment Monitoring: Evaluating the efficacy of therapeutic interventions and monitoring changes in sexual function over time.
Structure
The IIEF consists of 15 items, divided into five distinct domains:
- Erectile Function: Items 1, 2, 3, 4, 5, 15
- Orgasmic Function: Items 9, 10
- Sexual Desire: Items 11, 12
- Intercourse Satisfaction: Items 6, 7, 8
- Overall Satisfaction: Items 13, 14
Respondents are asked to rate their experiences over the past four weeks, with responses capturing the frequency and severity of symptoms. The IIEF provides a comprehensive profile of sexual function, encompassing both physiological and psychological aspects of sexual health.
Application
- Clinical Use: The IIEF is used by urologists, andrologists, and other healthcare professionals specializing in sexual medicine. It aids in the diagnosis of erectile dysfunction and other sexual disorders, providing valuable information for treatment planning and patient counseling.
- Research Use: In research settings, the IIEF is employed to assess the prevalence and correlates of erectile dysfunction. It is also used in clinical trials to measure the impact of interventions on sexual function, serving as a primary or secondary endpoint in studies evaluating the efficacy of ED treatments.
Psychometric Properties
The IIEF demonstrates strong psychometric properties:
- Reliability: The IIEF exhibits high internal consistency, with Cronbach’s alpha coefficients ranging from 0.73 to 0.99 across different domains, indicating that the items reliably measure the respective aspects of erectile function and sexual health. Test-retest reliability is also high, supporting the stability of the measure over time.
- Validity: The IIEF shows excellent construct validity, correlating well with other established measures of sexual function and related psychological constructs. It also displays strong discriminant validity, effectively distinguishing between individuals with varying degrees of erectile dysfunction.
- Factor Structure: Confirmatory factor analysis of the IIEF supports its multidimensional structure, reflecting the five distinct domains it aims to measure. The factor structure is consistent across diverse populations, underscoring its robustness and applicability.
Translation and Adaptation
The IIEF has been translated into multiple languages and validated in various cultural contexts, ensuring its relevance and accuracy in diverse populations. This widespread applicability makes the IIEF a valuable tool for assessing erectile function globally.
Conclusion
The International Index of Erectile Function (IIEF) is a reliable and valid instrument for assessing erectile function and sexual health in men. Its strong psychometric properties, comprehensive coverage of sexual function dimensions, and adaptability across cultures make it an essential tool for clinicians and researchers. The IIEF facilitates the identification, diagnosis, and treatment of erectile dysfunction, contributing significantly to the understanding and management of sexual health disorders.
References
Rosen R, Riley A, Wagner G, et al. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology, 1997, 49: 822-830.